A mechanistic approach to understanding the factors affecting drug absorption: a review of fundamentals MN Martinez, GL Amidon The Journal of Clinical Pharmacology 42 (6), 620-643, 2002 | 804 | 2002 |
Pharmacology of the fluoroquinolones: a perspective for the use in domestic animals M Martinez, P McDermott, R Walker The Veterinary Journal 172 (1), 10-28, 2006 | 528 | 2006 |
Dosing regimen matters: the importance of early intervention and rapid attainment of the pharmacokinetic/pharmacodynamic target MN Martinez, MG Papich, GL Drusano Antimicrobial agents and chemotherapy 56 (6), 2795-2805, 2012 | 249 | 2012 |
Applying biopharmaceutical classification system (BCS) criteria to predict oral absorption of drugs in dogs: challenges and pitfalls MG Papich, MN Martinez The AAPS journal 17, 948-964, 2015 | 165 | 2015 |
Pharmacogenetic and metabolic differences between dog breeds: their impact on canine medicine and the use of the dog as a preclinical animal model S Fleischer, M Sharkey, K Mealey, EA Ostrander, M Martinez The AAPS journal 10, 110-119, 2008 | 134 | 2008 |
Applying the biopharmaceutics classification system to veterinary pharmaceutical products: Part II. Physiological considerations M Martinez, G Amidon, L Clarke, WW Jones, A Mitra, J Riviere Advanced Drug Delivery Reviews 54 (6), 825-850, 2002 | 129 | 2002 |
In vitro and in vivo considerations associated with parenteral sustained release products: a review based upon information presented and points expressed at the 2007 Controlled … M Martinez, M Rathbone, D Burgess, M Huynh Journal of Controlled Release 129 (2), 79-87, 2008 | 127 | 2008 |
The pharmacogenomics of P‐glycoprotein and its role in veterinary medicine M Martinez, S Modric, M Sharkey, L Troutman, L Walker, K Mealey Journal of Veterinary Pharmacology and Therapeutics 31 (4), 285-300, 2008 | 104 | 2008 |
AUC/MIC: a PK/PD index for antibiotics with a time dimension or simply a dimensionless scoring factor? PL Toutain, A Bousquet-Melou, M Martinez Journal of Antimicrobial Chemotherapy 60 (6), 1185-1188, 2007 | 104 | 2007 |
Applying the Biopharmaceutics Classification System to veterinary pharmaceutical products: Part I: Biopharmaceutics and formulation considerations M Martinez, L Augsburger, T Johnston, WW Jones Advanced Drug Delivery Reviews 54 (6), 805-824, 2002 | 87 | 2002 |
What does it “mean”? A review of interpreting and calculating different types of means and standard deviations MN Martinez, MJ Bartholomew Pharmaceutics 9 (2), 14, 2017 | 82 | 2017 |
Interspecies allometric scaling. Part I: prediction of clearance in large animals I Mahmood, M Martinez, RP Hunter Journal of veterinary pharmacology and therapeutics 29 (5), 415-423, 2006 | 77 | 2006 |
The biopharmaceutics risk assessment roadmap for optimizing clinical drug product performance A Selen, PA Dickinson, A Müllertz, JR Crison, HB Mistry, MT Cruañes, ... Journal of Pharmaceutical Sciences 103 (11), 3377-3397, 2014 | 74 | 2014 |
Mathematical modeling and simulation in animal health. Part III: Using nonlinear mixed‐effects to characterize and quantify variability in drug pharmacokinetics C Bon, PL Toutain, D Concordet, R Gehring, T Martin‐Jimenez, J Smith, ... Journal of veterinary pharmacology and therapeutics 41 (2), 171-183, 2018 | 70 | 2018 |
Patient variation in veterinary medicine: part I. Influence of altered physiological states M Martinez, S Modric Journal of veterinary pharmacology and therapeutics 33 (3), 213-226, 2010 | 69 | 2010 |
Modified release drug delivery in veterinary medicine MJ Rathbone, MN Martinez Drug discovery today 7 (15), 823-829, 2002 | 68 | 2002 |
Factors influencing the use and interpretation of animal models in the development of parenteral drug delivery systems MN Martinez The AAPS journal 13 (4), 632-649, 2011 | 62 | 2011 |
Factors influencing the gastric residence of dosage forms in dogs MN Martinez, MG Papich Journal of pharmaceutical sciences 98 (3), 844-860, 2009 | 62 | 2009 |
Breakout session summary from AAPS/CRS joint workshop on critical variables in the in vitro and in vivo performance of parenteral sustained release products MN Martinez, MJ Rathbone, D Burgess, M Huynh Journal of Controlled Release 142 (1), 2-7, 2010 | 58 | 2010 |
Challenges in exploring the cytochrome P450 system as a source of variation in canine drug pharmacokinetics MN Martinez, L Antonovic, M Court, M Dacasto, J Fink-Gremmels, ... Drug metabolism reviews 45 (2), 218-230, 2013 | 54 | 2013 |